Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MUU vs MRNA✓SelectedUSD · MRNAMUU vs MRNA performance historyLatest closeAs of-27.90%11/20
Stock and ETF performance explorer

MUU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+670.0%
MRNA return
+233.8%
Excess return
+436.1%
Maximum drawdown
-84.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-27.9%-2.2%-25.7%-27.6%
7D-43.9%-12.7%-31.2%-42.8%
30D-63.2%-20.7%-42.6%-62.0%
3M-69.8%+46.3%-116.1%-71.0%
6M-61.9%+305.2%-367.1%-75.7%
YTD+93.5%+561.2%-467.7%-7.9%
1Y+271.8%+772.1%-500.3%+52.1%
All+670.0%+233.8%+436.1%+239.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling